COMMUNIQUÉS West-GlobeNewswire

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
28/01/2019
FT. MYERS, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth quarter and fiscal [...]
Protalix BioTherapeutics to Present Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
28/01/2019
~Oral presentation to include pharmacokinetic and anti-drug antibody data for first 15 patients enrolled~ CARMIEL, Israel, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX [...]
EyePoint Pharmaceuticals Appoints David Guyer, M.D., to Board of Directors
28/01/2019
– Dr. Guyer is a Successful Ophthalmology Entrepreneur with Deep Business and Clinical Experience in Advancing Treatments for Ocular Diseases - WATERTOWN, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) -- EyePoint [...]
CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer
28/01/2019
Drug development veteran to lead CureVac’s global product development efforts as the company looks to advance its pipeline of mRNA-based products TÜBINGEN, Germany and BOSTON, Jan. 28, 2019 (GLOBE NEWSWIRE) -- CureVac [...]
Trevena Announces Receipt of Type A Meeting Minutes and Provides Regulatory Update for Oliceridine
28/01/2019
– Company announces initial path forward on oliceridine NDA – – Company to host conference call on Monday, January 28 at 8:30 a.m. ET – CHESTERBROOK, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) [...]
Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet
28/01/2019
1.1 million square foot Pure Sunfarms facility on track to reach full production capacity in first half 2019 VICTORIA, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or [...]
Cerecor Announces U.S. Headquarters Move Into Pharmaceutical Corridor of Rockville, Maryland
28/01/2019
ROCKVILLE, Md., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in [...]
Tetra Bio-Pharma Files Patent Application to Protect PPP001
28/01/2019
Tetra Natural Health’s Distribution Partner Expands Distribution Network for the Hemp Energy Drink ORLEANS, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or the “ Company ”) (TSX VENTURE: [...]
111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution
28/01/2019
SHANGHAI, China, Jan. 28, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced it has signed a strategic cooperation [...]
Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma
28/01/2019
- Initial Clinical Data Anticipated in Second Half of 2020 - CAMBRIDGE, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a biotechnology company developing monoclonal microbials [...]
Arrayit Corporation Allergy Testing Services Endorsed by Leading Pediatrics Medical Group
28/01/2019
Sunnyvale, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its proprietary microarray-based finger stick allergy testing services are [...]
Novo Nordisk A/S: Share repurchase programme
28/01/2019
Bagsværd, Denmark, 28 January 2019 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Unilever and Bio-on present My Kai the new line of ultra-green sun creams
28/01/2019
The partnership between Unilever and Bio-on has created new brand My Kai, set to enter the cosmetics market with the first line of eco-friendly sun creams. It is the world’s first product made from the new cosmetic [...]
Nicox Establishes High-Profile Glaucoma Clinical Advisory Board
28/01/2019
Press Release Nicox Establishes High-Profile Glaucoma Clinical Advisory Board ............................................... Key U.S. clinical investigators and opinion leaders to support and guide the development of [...]
Nicox constitue un Comité consultatif clinique d'experts sur le glaucome
28/01/2019
Communiqué de presse Nicox constitue un Comité consultatif clinique d'experts sur le glaucome ................................................. Développement des thérapies donneuses d'oxyde nitrique innovantes de Nicox [...]
Biocartis Group NV: Disclosure of a transparency notification
28/01/2019
PRESS RELEASE : REGULATED INFORMATION 28 January 2019, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 28 January 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
EDITORIAL ON POSITIVE DATA FOR BARHEMSYS™ RESCUE TREATMENT OF POST-OPERATIVE NAUSEA & VOMITING (PONV) PUBLISHED IN ANESTHESIOLOGY
28/01/2019
Cambridge, UK and Indianapolis, US – 28 January 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) welcomes an editorial published in the leading peer-reviewed journal Anesthesiology , [...]
Genmab Announces that the patents asserted against DARZALEX® in the United States have been declared invalid by summary judgment.
26/01/2019
Company Announcement Patents asserted against Janssen Biotech, Inc. & Genmab in the United States have been declared invalid by summary judgment Copenhagen, Denmark; January 26, 2019 – Genmab A/S (Nasdaq Copenhagen [...]
Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
25/01/2019
WARREN, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced the closing and funding of its [...]

Pages